TAK-188
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TAK-188, covering 2026-04-24 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors [Phase 1, Phase 2]